It is a retrospective cohort study aiming to describe the characteristics, management andprognosis of vaccinated patients hospitalized in the intensive care unit (ICU), incomparison with non-vaccinated patients.
In December 2019 started the first wave of Sars-Cov-2 virus infections in Wuhan, China :
the start of a major, deadly global pandemic, which has so far caused more than 6 million
deaths worldwide. In response to the scale of this pandemic, a large-scale vaccination
campaign was rapidly in place, starting in December 2020. Despite this measure, admission
of vaccinated patients to intensive care has been noticed. The aim of this study is to
describe the characteristics, management and prognosis of vaccinated patients
hospitalized in the intensive care unit (ICU), in comparison with non-vaccinated
patients.
Inclusion Criteria:
- Adult patient with Sars-Cov-2 pneumonia confirmed by positive reverse transcription
polymerase chain reaction (RT-PCR) assay and hospitalized in the general intensive
care unit of the CHR de Metz-Thionville, between 01/03/2020 and 01/06/2022.
Exclusion Criteria:
- missing data for primary or secondary outcomes
CHR Metz-Thionville/Hopital Mercy
Metz 2994160, France
Guillaume LOUIS, MD, Principal Investigator
CHR Metz Thionville Hopital Mercy